Flupentixol

DRUG5 trials

Sponsors

Universitair Medisch Centrum Utrecht, Les Hopitaux Universitaires De Strasbourg, University of Bremen, Hannover Medical School, Taichung Veterans General Hospital

Conditions

Antipsychotic AgentsAnxiety DisordersCentral Nervous System DiseasesClinical TherapyDementiaDepressionFlupentixolMetabolic Syndrome

Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

TerminatedNCT02374567

Hannover Medical SchoolAnxiety Disorders, Dementia, Depression +2

Start: 2015-01-31End: 2017-06-28Updated: 2018-02-28

A prospective, randomized, and controlled study comparing two treatment strategies (Dose REduction of Antipsychotics vs. Maintenance treatment) in patients with schizophrenia spectrum disorder after Stratification based on patients’ psychotic PHENotype: a personalized medicine approach

Not yet recruitingCTIS2023-509558-80-00

Les Hopitaux Universitaires De StrasbourgPatient with a diagnosis of schizophrenia spectrum disorder (SSD): schizophrenia, schizoaffective disorder or brief psychotic episode according to DSM-5, schizophreniform

Target: 288Updated: 2025-07-17

Phase 4

Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia

CompletedNCT01164059

University of BremenSchizophrenia

Start: 2010-02-28End: 2014-03-31Updated: 2015-06-22

Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients

CompletedNCT04898270

Taichung Veterans General HospitalAntipsychotic Agents, Central Nervous System Diseases, Clinical Therapy +5

Start: 2019-12-19End: 2021-04-20Updated: 2021-05-24

A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for schizophrenia compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment.

RecruitingCTIS2023-506602-39-00

Universitair Medisch Centrum Utrechtschizoaffective disorder, schizophrenia, schizophrenifom disorder

Start: 2024-08-01Target: 310Updated: 2025-03-04

Related Papers

Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study.

2016-06-0240 citations